Astellas Announces Commitments to 3rd Phase of GHIT Fund Replenishment

Astellas Pharma Inc. announced that it has committed to supporting the 3rd phase of the Global Health Innovative Technology Fund, together with a cross-sector group of funding partners.

Scroll to Top